Recherche
-
Impact of the COVID-19 pandemic and its control measures on cardiovascular and antidiabetic drugs use in France in 2020: a nationwide repeated cohort study
(European Journal of Epidemiology. pp. 1-11, 2022-09-21)Article de revue -
Use of cardiovascular and antidiabetic drugs during COVID19 epidemic in France
(Fundamental & Clinical Pharmacology. vol. 36, n° S1, pp. 94-95, 2022-06)Article de revue -
Myocardial infarction associated with erenumab: a case report.
(PHARMACOTHERAPY, 2022-05-27)Article de revueLibre accès -
Heart failure and atrial tachyarrhythmia on abiraterone: A pharmacovigilance study
(Arch Cardiovasc Dis. vol. 113, n° 1, pp. 9-21, 2020)Article de revue -
High-Dimensional Propensity Score-Adjusted Case-Crossover for Discovering Adverse Drug Reactions from Computerized Administrative Healthcare Databases
(Drug Safety, 2022-02-18)Article de revue -
A meta-epidemiological study found lack of transparency and poor reporting of disproportionality analyses for signal detection in pharmacovigilance databases
(Journal of Clinical Epidemiology, 2021-07-27)Article de revue -
Risk of first ischemic stroke and use of antidopaminergic antiemetics: A nationwide case-time-control study
(Fundamental and Clinical Pharmacology. vol. 36, pp. 22-23, 2022-06)Article de revue -
Class-imbalanced subsampling lasso algorithm for discovering adverse drug reactions
(Statistical Methods in Medical Research. vol. 27, n° 3, pp. 785-797, 2018-03)Article de revue -
Impact of cancer diagnosis on persistence of oral antidiabetic drugs
(Diabetes Research and Clinical Practice. vol. 139, pp. 323-330, 2018-05)Article de revue -
Antidepressants during pregnancy: a French drug utilisation study in EFEMERIS cohort
(European Archives of Psychiatry and Clinical Neuroscience. vol. 269, n° 7, pp. 841-849, 2019-10)Article de revue